Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 15.40 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,374.9 Cr 0.4% -0.4% 39.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -2% -8.4% 14.3% Stock Analytics
DIVIS LABORATORIES ₹175,673.0 Cr -0.2% 7.5% 48% Stock Analytics
CIPLA ₹118,908.0 Cr -0.3% -2.6% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,106.0 Cr -1% -4.1% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,494.0 Cr 0.3% 8% 6.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.4%

-0.4%

39.9%

SENSEX

-0.4%

0.3%

8.7%


You may also like the below Video Courses